Contribution of bone morphogenetic protein-2 to aortic valve calcification in aged rat

Journal of Pharmacological Sciences

Volumn 115, Issue 1, 2011, Pages 8-14

  Seya, Kazuhiko ^a   Yu, Zaiqiang ^a   Kanemaru, Kouta ^a   Daitoku, Kazuyuki ^a   Akemoto, Yui ^a   Shibuya, Hiroyuki ^a   Fukuda, Ikuo ^a   Okumura, Ken ^a   Motomura, Shigeru ^a   Furukawa, Ken Ichi ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

Aging; Aortic valve; BMP 2; Calcification

Indexed keywords

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; CALCIUM; DEXAMETHASONE; GLYCEROL 2 PHOSPHATE; PHOSPHATE; TRANSCRIPTION FACTOR MSX2; TRANSCRIPTION FACTOR OSTERIX; TUMOR NECROSIS FACTOR ALPHA;

AGED; AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA VALVE CALCIFICATION; AORTA VALVE STENOSIS; ARTICLE; CALCIFICATION; CONTROLLED STUDY; DISEASE COURSE; ENZYME ACTIVITY; GENE ACTIVATION; GENE EXPRESSION REGULATION; HISTOPATHOLOGY; INFLAMMATION; MALE; MOLECULAR MECHANICS; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN FUNCTION; RAT; RISK FACTOR;

EID: 79952397401     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.10198FP     Document Type: Article

References (20)

1. Stewart BF, Siscovick D, Lind BK, Gardin JM, Gottdiener JS, Smith VE, et al. Clinical factors associated with calcific aortic valve disease. J Am Col Cardiol. 1997;29:630-634. (Pubitemid 27116107)
2. Otto CM, Lind BK, Kitzman DW, Gersh BJ, Siscovick P, Siscovick D. Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med. 1999;341:142-147. (Pubitemid 29325741)
3. Sell S, Scully RE. Aging changes in the aortic and mitral valves. Am J Pathol. 1965;46:345-365.
4. Parolari A, Loardi C, Mussoni L, Cavallotti L, Camera M, Biglioli P, et al. Nonrheumatic calcific aortic stenosis: an overview from basic science to pharmacological prevention. Eur J Cardiothorac Surg. 2009;35:493-504.
5. Rajamannan NM, Subramaniam M, Springett M, Sebo TC, Niekrasz M, McConnell JP, et al. Atorvastatin inhibits hypercholesterolemia-induced cellular proliferation and bone matrix production in the rabbit aortic valve. Circulation. 2002;105:2660-2665. (Pubitemid 34596044)
6. Rajamannan NM, Subramaniam M, Rickard D, Stock SR, Donovan J, Springett M, et al. Human aortic valve calcification is associated with an osteoblast phenotype. Circulation. 2003; 107:2181-2184. (Pubitemid 36547209)
7. Hakuno D, Kimura N, Yoshioka M, Fukuda K. Molecular mechanisms underlying the onset of degenerative aortic valve disease. J Mol Med. 2009;87:17-24.
8. Mohler ER III, Gannon F, Reynolds C, Zimmerman R, Keane MG, Kaplan FS. Bone formation and inflammation in cardiac valves. Circulation. 2001;103:1522-1528. (Pubitemid 32226259)
9. Jian B, Narula N, Li QY, Mohler ER III, Levy RJ. Progression of aortic valve stenosis: TGF-beta1 is present in calcified aortic valve cusps and promotes aortic valve interstitial cell calcification via apoptosis. Ann Thorac Surg. 2003;75:457-465. (Pubitemid 36184488)
10. Euler-Taimor G, Heger J. The complex pattern of SMAD signaling in the cardiovascular system. Cardiovasc Res. 2006;69:15-25. (Pubitemid 41814808)
11. Rajamannan NM, Subramaniam M, Caira F, Stock SR, Spelsberg TC. Atorvastatin inhibits hypercholesterolemia-induced calcification in the aortic valves via the Lrp5 receptor pathway. Circulation. 2005;112 Suppl 9:I229-I234.
12. Gu X, Masters KS. Role of the MAPK/ERK pathway in valvular interstitial cell calcification. Am J Physiol Heart Circ Physiol. 2009;296:H1748-H1757.
13. Kanemaru K, Seya K, Miki I, Motomura S, Furukawa K-I. Calcification of aortic smooth muscle cells isolated from spontaneously hypertensive rats. J Pharmacol Sci. 2008;106:280-286. (Pubitemid 351366348)
14. Miki I, Seya K, Motomura S, Furukawa K-I. Role of corticotropin-releasing factor receptor type 2β in urocortin-induced vasodilation of rat aortas. J Pharmacol Sci. 2004;96:170-176. (Pubitemid 39469608)
15. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25:402-408. (Pubitemid 34164012)
16. Towler DA, Shao JS, Cheng SL, Pingsterhaus JM, Loewy AP. Osteogenic regulation of vascular calcification. Ann N Y Acad Sci. 2006;1068:327-333. (Pubitemid 43824164)
17. Franceschi RT, Xiao G, Jiang D, Gopalakrishnan R, Yang S, Reith E. Multiple signaling pathways converge on the Cbfa1/ Runx2 transcription factor to regulate osteoblast differentiation. Connect Tissue Res. 2003;44:109-116. (Pubitemid 36395431)
18. Tintut Y, Patel J, Parhami F, Demer LL. Tumor necrosis factor-α promotes in vitro calcification of vascular cells via the cAMP pathway. Circulation. 2000;102:2636-2642.
19. Semevolos SA, Nixon AJ, Fortier LA, Strassheim ML, Haupt J. Age related expression of molecular regulators of hypertrophy and maturation in articular cartilage. J Orthp Res. 2006;24: 1773-1781. (Pubitemid 44203309)
20. Agmon Y, Khandheria BK, Tajik AJ, Seward JB, Sicks JD, Fought AJ, et al. Inflammation, infection, and aortic valve sclerosis: insights from the Olmsted country (Minnesota) population. Atherosclerosis. 2004;174:337-342. (Pubitemid 38597091)